Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3832)
All Articles published online
|
Nov 14, 2010 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino JI, Takeuchi M, Kubota K. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J Gastroenterol 2010; 16(42): 5334-5341 [PMID: 21072897 DOI: 10.3748/wjg.v16.i42.5334] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i42/5334.htm |
| Number | Citing Articles |
| 1 |
N. Lin, H. Zhang, Q. Su. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress. Diabetes & Metabolism 2012; 38(3): 250 doi: 10.1016/j.diabet.2012.01.003
|
| 2 |
Hiroyuki Hachiya, Yoshikazu Miura, Ken‐ichi Inoue, Kyung Hwa Park, Masayoshi Takeuchi, Keiichi Kubota. Advanced glycation end products impair glucose‐induced insulin secretion from rat pancreatic β‐cells. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(2): 134 doi: 10.1002/jhbp.12
|
| 3 |
Masayoshi Takeuchi. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases. Diagnostics 2016; 6(2): 23 doi: 10.3390/diagnostics6020023
|
| 4 |
Ejazul Haque, Mohd Kamil, Adria Hasan, Safia Irfan, Saba Sheikh, Aisha Khatoon, Aamir Nazir, Snober S Mir. Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis. Glycobiology 2020; 30(1): 2 doi: 10.1093/glycob/cwz073
|
| 5 |
Masashi Yanaki, Masayuki Kobayashi, Atsushi Aruga, Minoru Nomura, Makoto Ozaki. In Vivo Antitumor Effects of MK615 Led by PD-L1 Downregulation. Integrative Cancer Therapies 2018; 17(3): 646 doi: 10.1177/1534735418766403
|
| 6 |
Takanobu Takata, Tadashi Ueda, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion. World Journal of Gastroenterology 2017; 23(27): 4910-4919 doi: 10.3748/wjg.v23.i27.4910
|
| 7 |
Sho-ichi Yamagishi, Takanori Matsui, Kei Fukami. Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk. Rejuvenation Research 2015; 18(1): 48 doi: 10.1089/rej.2014.1625
|
| 8 |
Marcus Hollenbach. The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). International Journal of Molecular Sciences 2017; 18(11): 2466 doi: 10.3390/ijms18112466
|
| 9 |
Hiromi Kan, Sho‐ichi Yamagishi, Ayako Ojima, Kei Fukami, Seiji Ueda, Masayoshi Takeuchi, Hideyuki Hyogo, Hiroshi Aikata, Kazuaki Chayama. Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis 2015; 29(6): 480 doi: 10.1002/jcla.21797
|
| 10 |
Kazuma Tago, Ken-ichi Inoue, Motoshi Ouchi, Yoshikazu Miura, Keiichi Kubota. Receptor for advanced glycation endproducts signaling cascades are activated in pancreatic fibroblasts, but not in the INS1E insulinoma cell line: Are mesenchymal cells major players in chronic inflammation?. Islets 2016; 8(5): 135 doi: 10.1080/19382014.2016.1212146
|
| 11 |
Xue-Peng Gong, Ying Tang, Yuan-Yuan Song, Guang Du, Juan Li. Comprehensive Review of Phytochemical Constituents, Pharmacological Properties, and Clinical Applications of Prunus mume. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.679378
|
| 12 |
Sho-ichi Yamagishi, Takanori Matsui. Role of receptor for advanced glycation end products (RAGE) in liver disease. European Journal of Medical Research 2015; 20(1) doi: 10.1186/s40001-015-0090-z
|
| 13 |
Liguo Lin, Kaihua Zhong, Zhongkai Sun, Guozhong Wu, Guodong Ding. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology 2012; 138(1): 11 doi: 10.1007/s00432-011-1067-0
|
| 14 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017; 9(6): 634 doi: 10.3390/nu9060634
|
| 15 |
Hui Han, Romain Desert, Sukanta Das, Zhuolun Song, Dipti Athavale, Xiaodong Ge, Natalia Nieto. Danger signals in liver injury and restoration of homeostasis. Journal of Hepatology 2020; 73(4): 933 doi: 10.1016/j.jhep.2020.04.033
|
| 16 |
Christian Bailly. Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot). Journal of Ethnopharmacology 2020; 246: 112215 doi: 10.1016/j.jep.2019.112215
|
| 17 |
Hanbei Chen, Yakui Li, Yemin Zhu, Lifang Wu, Jian Meng, Ning Lin, Dianqiang Yang, Minle Li, WenJin Ding, Xuemei Tong, Qing Su. Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species. Medicine 2017; 96(33): e7456 doi: 10.1097/MD.0000000000007456
|
| 18 |
Giancarlo Aldini, Giulio Vistoli, Milan Stefek, N. Chondrogianni, Tilman Grune, Jolanta Sereikaite, Izabela Sadowska-Bartosz, Grzegorz Bartosz. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radical Research 2013; 47(sup1): 93 doi: 10.3109/10715762.2013.792926
|
| 19 |
Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Masayoshi Takeuchi. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14711-3
|
| 20 |
M. Takeuchi, A. Sakasai-Sakai, T. Takata, T. Ueda, J. Takino, M. Tsutsumi, H. Hyogo, S. Yamagishi. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. Medical Hypotheses 2015; 84(5): 490 doi: 10.1016/j.mehy.2015.02.002
|
| 21 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Tadashi Ueda, Mikihiro Tsutsumi, Hideyuki Hyogo, Sho-ichi Yamagishi. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World Journal of Hepatology 2014; 6(12): 880-893 doi: 10.4254/wjh.v6.i12.880
|
| 22 |
Yadav Sangeeta Muthyalaiah, Bhavana Jonnalagadda, Cordelia Mano John, Sumathy Arockiasamy. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression. Glycoconjugate Journal 2021; 38(6): 717 doi: 10.1007/s10719-021-10031-x
|
| 23 |
Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World Journal of Hepatology 2015; 7(23): 2459-2469 doi: 10.4254/wjh.v7.i23.2459
|
| 24 |
Takashi Hoshino, Hitoshi Takagi, Atsushi Naganuma, Eri Koitabashi, Sanae Uehara, Naomi Sakamoto, Tomohiro Kudo, Ken Sato, Satoru Kakizaki. Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot “<italic>Prunus mume</italic>”. World Journal of Hepatology 2013; 5(10): 596-600 doi: 10.4254/wjh.v5.i10.596
|
| 25 |
Hsin-Lin Cheng, Wei-Tang Chang, Jiun-Ling Lin, Ming-Ching Cheng, Shih-Chien Huang, Shiuan-Chih Chen, Yue-Ching Wong, Chin-Lin Hsu. An Innovative Mei-Gin Formula Exerts Anti-Adipogenic and Anti-Obesity Effects in 3T3-L1 Adipocyte and High-Fat Diet-Induced Obese Rats. Foods 2023; 12(5): 945 doi: 10.3390/foods12050945
|